Nursing home patient access to prescription drugs is being squeezed as several market and regulatory factors have combined to increase the power pharmacy benefit managers have over long-term care pharmacies, an advocacy group warned federal officials last week.
The Alliance for Long-Term Care Pharmacy @ Home recently urged Congress to push CMS on Medicare beneficiary access to LTC pharmacy services at home in an open letter dated March 12. The Alliance for LTC Pharmacy @ Home is an initiative that grew from the efforts of the NCPA Long-Term Care Division, the American Society of Consultant Pharmacists, and the Senior Care Pharmacy Coalition.
President Biden in his State of the Union address last week vowed to end “Big Pharma’s” grip on prescription drug pricing and cut costs for seniors and taxpayers by another $200 million.
The Alliance for LTC Pharmacy @ Home recently submitted a letter to the House Budget Committee’s Health Task Force requesting information on improving health outcomes while reducing spending. The letter advocated for changes in federal policy that will improve access to the provision of long-term care pharmacy services at home.
If there’s one thing most Americans still agree on, it’s that the ever-increasing cost of healthcare is simply unsustainable. And while there is plenty of